{"id":174,"date":"2019-10-19T23:27:28","date_gmt":"2019-10-20T03:27:28","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/4-14-beta-2-antagonist\/"},"modified":"2022-03-16T13:04:25","modified_gmt":"2022-03-16T17:04:25","slug":"4-15-beta-2-antagonist","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/4-15-beta-2-antagonist\/","title":{"raw":"4.15 Beta-2 Antagonists","rendered":"4.15 Beta-2 Antagonists"},"content":{"raw":"Propranolol is a Beta-2 antagonist.\r\n\r\nMechanism of Action:<\/strong> Propranolol is a nonselective beta-blocker because of its inhibition of both Beta-1 and Beta-2 receptors.\r\n\r\nIndications for Use:<\/strong> Propranolol is used to treat high blood pressure, angina, various heart dysrhythmias (to lower the heart rate), and essential tremors. It is also used after a myocardial infarction to reduce mortality by decreasing heart workload, and in migraine prevention.\r\n\r\nNursing Considerations Across the Lifespan:<\/strong> Nonselective beta blockers must be used cautiously with clients who have co-existing asthma or chronic obstructive pulmonary disease (COPD) because of the effects on Beta-2 receptors that could potentially cause bronchoconstriction. It can also mask symptoms of hypoglycemia in diabetics. Use with caution in clients with impaired hepatic or renal function. Give immediate-release (IR) formulations on an empty stomach. Do not crush extended-release (ER) formulations. Propranolol ER is not considered a simple milligram-for-milligram substitute for conventional propranolol. Check blood pressure and apical pulse before giving drug; withhold and notify prescriber if apical pulse is less than 60 beats per minute or systolic blood pressure is less than 100 mm Hg, unless other parameters are provided. During IV administration, monitor blood pressure, ECG, and heart rate frequently. The most serious adverse effects include bronchoconstriction, hypotension, bradycardia, and signs of worsening heart failure. Other adverse effects are similar to selective beta blockers like metoprolol.\r\n\r\nPropranolol is safe to give to pediatric clients, with dose adjustments made according to response to medication.\u00a0 No dose adjustments are needed for renal or liver dysfunction.\r\n\r\nSafety Warning:<\/strong> Abrupt withdrawal of this drug may cause exacerbation of angina or a myocardial infarction. To discontinue this drug, gradually reduce dosage over 1 to 2 weeks.\r\n\r\nPatient Teaching & Education:<\/strong> Clients should be instructed to follow the medication dosing regimen.\u00a0 Stopping medication therapy abruptly may cause life-threatening arrhythmias.\u00a0 Clients should be instructed on how to self-assess pulse and blood pressure to evaluate medication effectiveness.\u00a0 The medication may cause increased susceptibility to orthostatic blood pressure changes and increased sensitivity to cold.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n\r\nNow let's take a closer look at the medication grid on propranolol in Table 4.15.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>.[\/footnote] <\/sup>Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n\r\nTable 4.15 Propranolol<\/a> Medication Grid\r\n\r\n\"Beta-2","rendered":"

Propranolol is a Beta-2 antagonist.<\/p>\n

Mechanism of Action:<\/strong> Propranolol is a nonselective beta-blocker because of its inhibition of both Beta-1 and Beta-2 receptors.<\/p>\n

Indications for Use:<\/strong> Propranolol is used to treat high blood pressure, angina, various heart dysrhythmias (to lower the heart rate), and essential tremors. It is also used after a myocardial infarction to reduce mortality by decreasing heart workload, and in migraine prevention.<\/p>\n

Nursing Considerations Across the Lifespan:<\/strong> Nonselective beta blockers must be used cautiously with clients who have co-existing asthma or chronic obstructive pulmonary disease (COPD) because of the effects on Beta-2 receptors that could potentially cause bronchoconstriction. It can also mask symptoms of hypoglycemia in diabetics. Use with caution in clients with impaired hepatic or renal function. Give immediate-release (IR) formulations on an empty stomach. Do not crush extended-release (ER) formulations. Propranolol ER is not considered a simple milligram-for-milligram substitute for conventional propranolol. Check blood pressure and apical pulse before giving drug; withhold and notify prescriber if apical pulse is less than 60 beats per minute or systolic blood pressure is less than 100 mm Hg, unless other parameters are provided. During IV administration, monitor blood pressure, ECG, and heart rate frequently. The most serious adverse effects include bronchoconstriction, hypotension, bradycardia, and signs of worsening heart failure. Other adverse effects are similar to selective beta blockers like metoprolol.<\/p>\n

Propranolol is safe to give to pediatric clients, with dose adjustments made according to response to medication.\u00a0 No dose adjustments are needed for renal or liver dysfunction.<\/p>\n

Safety Warning:<\/strong> Abrupt withdrawal of this drug may cause exacerbation of angina or a myocardial infarction. To discontinue this drug, gradually reduce dosage over 1 to 2 weeks.<\/p>\n

Patient Teaching & Education:<\/strong> Clients should be instructed to follow the medication dosing regimen.\u00a0 Stopping medication therapy abruptly may cause life-threatening arrhythmias.\u00a0 Clients should be instructed on how to self-assess pulse and blood pressure to evaluate medication effectiveness.\u00a0 The medication may cause increased susceptibility to orthostatic blood pressure changes and increased sensitivity to cold.[1]<\/sup><\/a><\/sup><\/p>\n

Now let’s take a closer look at the medication grid on propranolol in Table 4.15.[2]<\/sup><\/a> <\/sup>Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n

Table 4.15 Propranolol<\/a> Medication Grid<\/p>\n

\"Beta-2<\/p>\n

Media Attributions<\/h2>